Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,250 | N/A | N/A | N/A | -18,540 |
| Depreciation Amortization | 3,120 | N/A | N/A | N/A | 2,960 |
| Accounts receivable | 1,228 | N/A | N/A | N/A | -599 |
| Accounts payable and accrued liabilities | 506 | N/A | N/A | N/A | -432 |
| Other Working Capital | 9,360 | N/A | N/A | N/A | 2,570 |
| Other Operating Activity | -12,944 | -12,634 | -5,532 | 1,212 | 1,021 |
| Operating Cash Flow | $-20,980 | $-12,634 | $-5,532 | $1,212 | $-13,020 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 16,994 | 15,514 | 9,233 | 12,475 | 7,918 |
| PPE Investments | -8,260 | -6,391 | -4,429 | -1,922 | -4,370 |
| Purchase Sale Intangibles | -639 | N/A | N/A | N/A | -1,158 |
| Other Investing Activity | -4 | 0 | 0 | 0 | -8 |
| Investing Cash Flow | $8,730 | $9,123 | $4,804 | $10,553 | $3,540 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 2,073 | 1,960 | N/A | 3,001 |
| Debt Repayment | -210 | -1,597 | -870 | -487 | -1,523 |
| Common Stock Issued | 1,487 | 1,203 | 620 | 481 | 237 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -115 |
| Other Financing Activity | -7 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $1,270 | $1,679 | $1,710 | $-6 | $1,600 |
| Beginning Cash Position | 13,670 | 13,675 | 13,675 | 13,675 | 21,550 |
| End Cash Position | 2,690 | 11,843 | 14,657 | 25,434 | 13,670 |
| Net Cash Flow | $-10,970 | $-1,832 | $982 | $11,759 | $-7,880 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,980 | -12,634 | -5,532 | 1,212 | -13,020 |
| Capital Expenditure | -8,269 | -6,400 | -4,438 | -1,922 | -4,374 |
| Free Cash Flow | -29,249 | -19,034 | -9,970 | -710 | -17,394 |